ArticleJournal of cardiothoracic surgery2025
Combined with chemotherapy and radiotherapy is effective in improving prognosis: a case of primary mediastinal embryonal carcinoma.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary mediastinal embryonal carcinoma is a disease characterized by pathological features similar to those of stem cell malignancies. Due to its undifferentiated nature and the potential for extensive metastasis, the prognosis of this disease is usually poor. Its overall incidence rate is less than 0.2/100,000 individuals, primarily affecting young adults aged 15 to 35, with a higher prevalence among males. The 5-year survival rate is less than 30%. CASE PRESENTATION: In this report, we report a 28-year-old man with a large anterior mediastinal tumor who underwent resection of the anterior mediastinal tumor after imaging and focal puncture biopsy. The final diagnosis was primary mediastinal embryonal carcinoma. This patient has been in long-term survival without recurrence for 8 years after surgery, during which he regularly received treatment and underwent follow-up.
conclusionIn the diagnosis and treatment of primary mediastinal embryonal carcinoma, changes in AFP levels are highly relevant and can be used to evaluate the outcome of surgery. At the same time, patients should also receive a complete treatment plan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.